30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
Gianni Bonadonna(Hospital Clínico Universitario de Valencia), Pinuccia Valagussa(Fondazione Michelangelo), Milvia Zambetti(Hospital Clínico Universitario de Valencia), Angela Moliterni(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvana Pilotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Luca Gianni(Fondazione Michelangelo), Maria Grazia Daidone(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 252
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
|Cell|2011|1.4k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k